Cover
Cover | Jun. 02, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 2, 2021 |
Entity File Number | 001-37467 |
Entity Registrant Name | Catabasis Pharmaceuticals, Inc. |
Entity Central Index Key | 0001454789 |
Entity Tax Identification Number | 26-3687168 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 100 High Street |
Entity Address, Address Line Two | 28th Floor |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02110 |
City Area Code | 617 |
Local Phone Number | 349-1971 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | CATB |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |